Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
The Life Sciences Report
Menu
Articles
Biotechnology / Pharmaceuticals
Cannabis
Healthcare Services
Life Sciences Tools & Diagnostics
Medical Devices
Nutraceuticals
Psychedelics
Disclosures
Featured news in
The Life Sciences Report
Sproutly Canada Inc.
(SPR:CSE; SRUTF:OTCQB)
The Future of Beverages in the Cannabis Sector: Sproutly (CSE: SPR) (OTCQB: SRUTF), Hexo Corp., The Green Organic Dutchman Ltd. (11/8/2018)
view
DURECT Corp.
(DRRX:NASDAQ)
DURECT Corporation Announces Third Quarter 2018 Financial Results and Provides Corporate Update (11/7/2018)
view
Caladrius Biosciences Inc.
(CLBS:NASDAQ)
Caladrius Biosciences Appoints Cynthia Schwalm to Board of Directors (11/8/2018)
view
Celgene Corp.
(CELG:NASDAQ)
Prothena (PRTA) Reports Narrower-Than-Expected Loss in Q3 (11/8/2018)
view
MiMedx Group Inc.
(MDXG:NASDAQ)
Jack Henry & Associates Set to Join S&P 500; EQT, Equitrans Midstream, MasTec to Join S&P MidCap 400; Superior Energy Services, United Natural Foods to Join S&P SmallCap 600 (11/7/2018)
view
MiMedx Group Inc.
(MDXG:NASDAQ)
Today's Research Reports on Trending Tickers: Tandem Diabetes Care and MiMedx (11/8/2018)
view
Cesca Therapeutics Inc.
(KOOL:NASDAQ)
Cesca Therapeutics To Announce Financial Results For The Third Quarter Ended September 30, 2018 And Host Conference Call On November 14 (11/7/2018)
view
Cesca Therapeutics Inc.
(KOOL:NASDAQ)
Will Cesca Therapeutics (KOOL) Report Negative Earnings Next Week? What You Should Know (11/6/2018)
view
Athersys Inc.
()
Athersys Reports Third Quarter 2018 Results (11/6/2018)
view
MiMedx Group Inc.
(MDXG:NASDAQ)
MiMedx Receives Nasdaq Delisting Notification (11/7/2018)
view
MiMedx Group Inc.
(MDXG:NASDAQ)
MiMedx To Present Clinical And Scientific Studies At Desert Foot Conference (11/6/2018)
view
MiMedx Group Inc.
(MDXG:NASDAQ)
MiMedx Adopts Limited Duration Shareholder Rights Plan In Response To Delisting From Nasdaq (11/7/2018)
view
BrainStorm Cell Therapeutics Inc.
(BCLI:NASDAQ)
BrainStorm Cell Therapeutics to Present at November Clinical and Investor Conferences (11/7/2018)
view
ProMIS Neurosciences Inc.
(PMN:TSX; PMN:NCM)
ProMIS Neurosciences Discusses Critical Importance of Selectively Targeting the Root Cause of Alzheimer's Disease (11/6/2018)
view
RepliCel Life Sciences Inc.
(RP:TSX.V; REPCF:OTCQB)
RepliCel Life Sciences Appoints Head of Clinical and Regulatory Affairs (11/6/2018)
view
Celgene Corp.
(CELG:NASDAQ)
Corcept (CORT) Q3 Earnings In Line, Revenues Miss Estimates (11/5/2018)
view